Gene-Expression Profiling Predicts Recurrence in Dukes’ C Colorectal Cancer
- 1 September 2005
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 129 (3) , 874-884
- https://doi.org/10.1053/j.gastro.2005.06.066
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Genetic Tumor Markers With Prognostic Impact in Dukes’ Stages B and C Colorectal Cancer PatientsJournal of Clinical Oncology, 2003
- Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon CancerNew England Journal of Medicine, 2001
- Chromosome 18q allelic loss and prognosis in stage II and III colon cancerInternational Journal of Cancer, 1998
- Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.Journal of Clinical Oncology, 1998
- Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final ReportAnnals of Internal Medicine, 1995
- Allelic Loss of Chromosome 18q and Prognosis in Colorectal CancerNew England Journal of Medicine, 1994
- Prognostic significance of K-ras mutations in colorectal carcinomaGastroenterology, 1993
- Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancerGastroenterology, 1993
- Survival and acquired genetic alterations in colorectal cancerGastroenterology, 1992
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990